QQ客服 官方微博 反馈留言

	Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
	Wang, Guogan; Wang, Pengbo; Li, Yishi; Liu, Wenxian; Bai, Shugong; Zhen, Yang; Li, Dongye; Yang, Ping; Chen, Yu; Hong, Lang
	2016
卷号	95期号:9页码:e2947
ISSN号	0025-7974
DOI	10.1097/MD.0000000000002947
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6382757
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Wang, Guogan,Wang, Pengbo,Li, Yishi,et al. Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial[J],2016,95(9):e2947.
APA	Wang, Guogan.,Wang, Pengbo.,Li, Yishi.,Liu, Wenxian.,Bai, Shugong.,...&Wang, Sijia.(2016).Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.,95(9),e2947.
MLA	Wang, Guogan,et al."Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial".95.9(2016):e2947.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。